A positive IGRA indicates an immune response consistent with TB infection and requires assessment for active disease. BCG vaccination does not explain a positive IGRA. Symptoms, examination, chest imaging and sometimes sputum testing determine whether preventive treatment is appropriate. If the result was early after a contact, a negative may need repetition 8–10 weeks after the final exposure. After successful treatment, the test may remain positive; keep the regimen and completion record rather than repeatedly testing to obtain a negative. New cough, fever or weight loss still needs prompt assessment.
A positive TB blood or skin test needs follow-up, but it does not by itself show contagious or active tuberculosis. Latent, or inactive, TB means infection without active disease. People with inactive TB do not spread it to others. Preventive treatment lowers the chance of future disease. Before choosing that treatment, a clinician must check for active TB, because active disease needs a different multidrug and public-health pathway.
TB tests identify an immune response to the bacteria, not the location or activity of infection. An IGRA blood test is not affected by prior BCG vaccination. A skin-test result may be affected by BCG, but it still needs clinical interpretation. Antibiotics for latent TB aim to eliminate infection before it progresses; success is documented by treatment completion rather than expecting the immune test to become negative.
Evaluation is appropriate after a positive test, a significant TB contact or screening before some immunosuppressive treatments. Risk of progression, age, HIV status, pregnancy, liver health, prior treatment and the source organism’s drug susceptibility affect the plan. Cough, fever, night sweats, weight loss or coughing blood requires prompt active-TB assessment. Tell the service about these symptoms before arriving so an appropriate pathway can be arranged.
Bring the actual report, date, prior tests, BCG history and any previous TB treatment record. An early negative result after exposure may need repetition 8–10 weeks after the final contact.
The evaluation includes symptoms, examination and chest imaging, with sputum or other testing when indicated. Preventive monotherapy must not start on the assumption that a positive test always means latent infection.
CDC favors short rifamycin-based three- or four-month regimens when appropriate. Options include weekly isoniazid/rifapentine, daily rifampin and daily isoniazid/rifampin; six- or nine-month isoniazid is an alternative. Age, pregnancy, HIV treatment, resistance and interactions determine suitability.
Arrange at least monthly assessment of adherence, symptoms and adverse effects. Baseline liver tests are selected for risk, including liver disease, HIV, alcohol use and pregnancy/postpartum circumstances, rather than required identically for everyone.
Bring all medicines, hormonal contraception and supplements, plus hepatitis, liver, alcohol-use and pregnancy information. Rifamycins interact with many drugs, including some HIV medicines, and can reduce the effectiveness of hormonal contraception. Ask whether an alternative or additional contraceptive method is needed. Confirm a practical way to take the full course and attend monthly reviews.
Contact the treatment team promptly for loss of appetite, persistent nausea, severe fatigue, abdominal pain, dark urine or jaundice. Do not dismiss those symptoms as an expected color change. Rifampin can harmlessly turn urine and other body fluids orange, but that does not explain every abnormal symptom. Call 911 for breathing difficulty, fainting or a severe allergic reaction. A severe rash needs immediate medical assessment. The clinician supplies medicine-specific instructions about stopping and assessment when possible toxicity occurs.
Monthly review checks doses taken, new symptoms and changes in interacting medicines. Repeat blood tests may be needed when baseline results are abnormal or risk is higher. Keep a record of the drugs, dates, imaging and treatment completion for future employment or school screening. A TB blood or skin test may remain positive after successful treatment and is usually not repeated to prove cure.
Ask whether the service performs the diagnostic workup, provides preventive treatment or coordinates with a TB/public-health clinic. Chest imaging, laboratory tests, medication and visits may involve different facilities and charges. Confirm the treating service, testing arrangements and any public-health referral. Symptoms suggesting active TB need prompt care rather than waiting for an elective preventive-treatment slot.
A positive TB blood or skin test needs follow-up, but it does not by itself show contagious or active tuberculosis. Latent, or inactive, TB means infection without active disease. People with inactive TB do not spread it to others. Preventive treatment lowers the chance of future disease. Before choosing that treatment, a clinician must check for active TB, because active disease needs a different multidrug and public-health pathway.
Evaluation is appropriate after a positive test, a significant TB contact or screening before some immunosuppressive treatments. Risk of progression, age, HIV status, pregnancy, liver health, prior treatment and the source organism’s drug susceptibility affect the plan. Cough, fever, night sweats, weight loss or coughing blood requires prompt active-TB assessment. Tell the service about these symptoms before arriving so an appropriate pathway can be arranged.
Bring the actual report, date, prior tests, BCG history and any previous TB treatment record. An early negative result after exposure may need repetition 8–10 weeks after the final contact.
The evaluation includes symptoms, examination and chest imaging, with sputum or other testing when indicated. Preventive monotherapy must not start on the assumption that a positive test always means latent infection.
CDC favors short rifamycin-based three- or four-month regimens when appropriate. Options include weekly isoniazid/rifapentine, daily rifampin and daily isoniazid/rifampin; six- or nine-month isoniazid is an alternative. Age, pregnancy, HIV treatment, resistance and interactions determine suitability.
Arrange at least monthly assessment of adherence, symptoms and adverse effects. Baseline liver tests are selected for risk, including liver disease, HIV, alcohol use and pregnancy/postpartum circumstances, rather than required identically for everyone.
Monthly review checks doses taken, new symptoms and changes in interacting medicines. Repeat blood tests may be needed when baseline results are abnormal or risk is higher. Keep a record of the drugs, dates, imaging and treatment completion for future employment or school screening. A TB blood or skin test may remain positive after successful treatment and is usually not repeated to prove cure.
A positive TB blood or skin test needs follow-up, but it does not by itself show contagious or active tuberculosis. Latent, or inactive, TB means infection without active disease. People with inactive TB do not spread it to others. Preventive treatment lowers the chance of future disease. Before choosing that treatment, a clinician must check for active TB, because active disease needs a different multidrug and public-health pathway.
The evaluation includes symptoms, examination and chest imaging, with sputum or other testing when indicated. Preventive monotherapy must not start on the assumption that a positive test always means latent infection.
Contact the TB clinician with the exact regimen, doses missed, symptoms and any new medicine. Different preventive regimens have different completion requirements, so do not double doses or restart from an online calendar. The clinician decides how to continue, whether further evaluation is needed and how completion will be documented. Symptoms suggesting active TB need prompt assessment before an ordinary follow-up visit.
BCG vaccination does not cause a positive IGRA. The result needs evaluation for TB infection and exclusion of active disease. Do not dismiss it using a skin-test explanation.
An immune response may persist after successful treatment. Completion is recorded with the regimen and dates, not by repeatedly checking for a negative IGRA.
Treatment for latent or inactive TB can prevent future active disease even when you have no symptoms and cannot spread TB. The clinician first excludes active disease. A positive blood or skin test alone cannot make that distinction. People with higher progression risk, including HIV or recent infection, are a priority for preventive treatment. Discuss the benefit, medicine interactions, liver risk, pregnancy and the organism’s susceptibility before choosing a regimen. CDC prefers suitable short rifamycin-based regimens, often three or four months. Isoniazid alternatives can last six or nine months. Symptoms suggesting active TB require prompt assessment and a different multidrug treatment pathway.
Bronx
932 E 174th St, Bronx, NY 10460
This clinic can be a starting point for positive-test review and treatment coordination. Call first to confirm imaging, laboratory, clinician, infection-control, and public-health needs; the card does not confirm on-site TB treatment capability. Serves West Farms, Crotona Park East, and nearby Bronx neighborhoods.
Queens
37-15 23rd Ave, Astoria, NY 11105
This clinic can be a starting point for positive-test review and treatment coordination. Call first to confirm imaging, laboratory, clinician, infection-control, and public-health needs; the card does not confirm on-site TB treatment capability. Serves Astoria, Ditmars, East Elmhurst, and nearby Queens neighborhoods.
Bronx
2063A Bartow Ave, Bronx, NY 10475
This clinic can be a starting point for positive-test review and treatment coordination. Call first to confirm imaging, laboratory, clinician, infection-control, and public-health needs; the card does not confirm on-site TB treatment capability. Serves Co-op City, Pelham Bay, Baychester, and nearby Bronx neighborhoods.
Brooklyn
341 Eastern Pkwy, Brooklyn, NY 11216
This clinic can be a starting point for positive-test review and treatment coordination. Call first to confirm imaging, laboratory, clinician, infection-control, and public-health needs; the card does not confirm on-site TB treatment capability. Serves Crown Heights, Prospect Heights, and nearby Brooklyn neighborhoods.
Long Island
232 W Old Country Rd, Hicksville, NY 11801
This clinic can be a starting point for positive-test review and treatment coordination. Call first to confirm imaging, laboratory, clinician, infection-control, and public-health needs; the card does not confirm on-site TB treatment capability. Serves Hicksville, Plainview, Bethpage, and nearby Nassau County communities.
Queens
80-10 Northern Blvd, Jackson Heights, NY 11372
This clinic can be a starting point for positive-test review and treatment coordination. Call first to confirm imaging, laboratory, clinician, infection-control, and public-health needs; the card does not confirm on-site TB treatment capability. Serves Jackson Heights, Elmhurst, Corona, and nearby Queens neighborhoods.
Queens
90-18 Sutphin Blvd, Jamaica, NY 11435
This clinic can be a starting point for positive-test review and treatment coordination. Call first to confirm imaging, laboratory, clinician, infection-control, and public-health needs; the card does not confirm on-site TB treatment capability. Serves Jamaica, Briarwood, Richmond Hill, and nearby Queens neighborhoods.
Queens
30-07 36th Ave, Astoria, NY 11106
This clinic can be a starting point for positive-test review and treatment coordination. Call first to confirm imaging, laboratory, clinician, infection-control, and public-health needs; the card does not confirm on-site TB treatment capability. Serves Long Island City, Astoria, Sunnyside, and nearby Queens neighborhoods.
Long Island
135 Mineola Blvd, Mineola, NY 11501
This clinic can be a starting point for positive-test review and treatment coordination. Call first to confirm imaging, laboratory, clinician, infection-control, and public-health needs; the card does not confirm on-site TB treatment capability. Serves Mineola, Garden City, Westbury, and nearby Nassau County communities.
Manhattan
259 1st Ave, New York, NY 10003
This clinic can be a starting point for positive-test review and treatment coordination. Call first to confirm imaging, laboratory, clinician, infection-control, and public-health needs; the card does not confirm on-site TB treatment capability. Serves StuyTown, the East Village, Gramercy, and nearby Manhattan neighborhoods.
Brooklyn
308 Graham Ave, Brooklyn, NY 11211
This clinic can be a starting point for positive-test review and treatment coordination. Call first to confirm imaging, laboratory, clinician, infection-control, and public-health needs; the card does not confirm on-site TB treatment capability. Serves Williamsburg, Greenpoint, Bushwick, and nearby Brooklyn neighborhoods.
Arrange an evaluation to discuss suitable care, preparation and follow-up with a clinician.